Invasive Breast Carcinoma — Trials

Invasive Breast Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

296 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 103
Recruiting: 41
Ph III recruiting: 3
Growth YoY: —
Industry share: 5%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 36.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (43)

clinicaltrialsPublishedShowing 51–100 of 115 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06268665	Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy	recruiting	Phase 2	86	University of California, DavisOTHER	1	Mar 4, 2026	clinicaltrials
NCT02530489	Nab-Paclitaxel and Atezolizumab Before Surgery in Treating Patients With Triple Negative Breast Cancer	completed	Phase 2	37	M.D. Anderson Cancer CenterOTHER	1	Feb 17, 2026	clinicaltrials